MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 39 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,245,000 | – | 382,619 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $21,079,000 | 8.43% |
| VHCP Management III, LLC | 1,258,964 | $5,262,000 | 3.07% |
| Granite Point Capital Management, L.P. | 3,045,407 | $12,730,000 | 1.23% |
| VHCP Management II, LLC | 743,876 | $3,109,000 | 0.91% |
| Endurant Capital Management LP | 437,299 | $1,828,000 | 0.72% |
| 683 Capital Management, LLC | 1,400,000 | $5,852,000 | 0.53% |
| Granite Point Capital Management, L.P. | 800,000 | $3,344,000 | 0.32% |
| Fosun International Ltd | 390,860 | $1,540,000 | 0.10% |
| Caption Management, LLC | 250,000 | $1,045,000 | 0.06% |
| Tekla Capital Management LLC | 328,436 | $1,373,000 | 0.06% |